176 related articles for article (PubMed ID: 17726035)
1. Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab.
Ideguchi H; Ohno S; Takase K; Hattori H; Kirino Y; Takeno M; Ishigatsubo Y
Rheumatology (Oxford); 2007 Oct; 46(10):1621-2. PubMed ID: 17726035
[No Abstract] [Full Text] [Related]
2. Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis.
Henzan T; Nagafuji K; Tsukamoto H; Miyamoto T; Gondo H; Imashuku S; Harada M
Am J Hematol; 2006 Jan; 81(1):59-61. PubMed ID: 16369976
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin rapidly diminished a severe lupus-associated macrophage association syndrome refractory to pulsed methylprednisolone and intravenous immunoglobulin.
Takizawa Y; Maruyama J; Setoguchi K
Scand J Rheumatol; 2009; 38(6):492-4. PubMed ID: 19922027
[No Abstract] [Full Text] [Related]
4. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
[TBL] [Abstract][Full Text] [Related]
5. Successful use of etanercept in the treatment of acute lupus hemophagocytic syndrome.
Takahashi N; Naniwa T; Banno S
Mod Rheumatol; 2008; 18(1):72-5. PubMed ID: 18161002
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hemophagocytic lymphohistiocytosis with alemtuzumab in systemic lupus erythematosus.
Keith MP; Pitchford C; Bernstein WB
J Clin Rheumatol; 2012 Apr; 18(3):134-7. PubMed ID: 22426581
[TBL] [Abstract][Full Text] [Related]
7. The case of SLE associated Sneddon-Wilkinson pustular disease successfully and safely treated with infliximab.
Naretto C; Baldovino S; Rossi E; Spriano M; Roccatello D
Lupus; 2009 Aug; 18(9):856-7. PubMed ID: 19578113
[No Abstract] [Full Text] [Related]
8. Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.
So MW; Koo BS; Kim YJ; Kim YG; Lee CK; Yoo B
Mod Rheumatol; 2014 Sep; 24(5):855-7. PubMed ID: 24517558
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of genital ulcers with infliximab in Behcet's disease.
Haugeberg G; Velken M; Johnsen V
Ann Rheum Dis; 2004 Jun; 63(6):744-5. PubMed ID: 15140785
[No Abstract] [Full Text] [Related]
10. Advanced refractory polymyositis responding to infliximab.
Anandacoomarasamy A; Howe G; Manolios N
Rheumatology (Oxford); 2005 Apr; 44(4):562-3. PubMed ID: 15695299
[No Abstract] [Full Text] [Related]
11. Successful treatment of refractory acute lupus haemophagocytic syndrome using rituximab: a case report.
Tomofuji Y; Ishikawa Y; Hattori K; Fujiwara M; Kita Y
Mod Rheumatol Case Rep; 2020 Jul; 4(2):222-228. PubMed ID: 33087000
[TBL] [Abstract][Full Text] [Related]
12. The successful use of infliximab in resistant relapsing polychondritis and associated scleritis.
Cazabon S; Over K; Butcher J
Eye (Lond); 2005 Feb; 19(2):222-4. PubMed ID: 15258602
[No Abstract] [Full Text] [Related]
13. TNF inhibition in SLE: where do we stand?
Aringer M; Smolen JS
Lupus; 2009 Jan; 18(1):5-8. PubMed ID: 19074162
[No Abstract] [Full Text] [Related]
14. Infliximab efficiency in refractory Wegener's granulomatosis.
Rozin A
Rheumatology (Oxford); 2003 Sep; 42(9):1124-5; author reply 1125-6. PubMed ID: 12923277
[No Abstract] [Full Text] [Related]
15. Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile.
Fujikawa K; Aratake K; Kawakami A; Aramaki T; Iwanaga N; Izumi Y; Arima K; Kamachi M; Tamai M; Huang M; Nakamura H; Nishiura Y; Origuchi T; Ida H; Eguchi K
Ann Rheum Dis; 2007 Jan; 66(1):136-7. PubMed ID: 17178762
[No Abstract] [Full Text] [Related]
16. [Drug-induced systemic lupus erythematosus: reports to The Netherlands Pharmacovigilance Centre Lareb].
van Rijthoven AW; van Roon JA
Ned Tijdschr Geneeskd; 2007 Apr; 151(14):839; author reply 839. PubMed ID: 17469329
[No Abstract] [Full Text] [Related]
17. Refractory vertebral sarcoidosis responding to infliximab.
Garg S; Garg K; Altaf M; Magaldi JA
J Clin Rheumatol; 2008 Aug; 14(4):238-40. PubMed ID: 18766126
[TBL] [Abstract][Full Text] [Related]
18. Infliximab-induced SLE-like syndrome involving the lung and pleura.
Diri E; Tello W; Ratnoff WD; Nugent K
Lupus; 2007; 16(9):764-6. PubMed ID: 17728373
[No Abstract] [Full Text] [Related]
19. [Biological treatment of rare inflammatory rheumatic diseases].
Baslund B
Ugeskr Laeger; 2008 Jun; 170(24):2150-2. PubMed ID: 18565301
[TBL] [Abstract][Full Text] [Related]
20. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
[No Abstract] [Full Text] [Related]
[Next] [New Search]
